SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 1.25%17.6M | 2,032.48%15.89M | 206.17%9.38M | -60.27%28.26M | -11.45%8.64M | -22.63%17.38M | -103.67%-822K | -81.43%3.06M | 67.62%71.14M | -62.18%9.76M |
Net income from continuing operations | 104.13%3.41M | 90.81%6.19M | -725.77%-5.61M | -1,015.55%-98.49M | -1,083.45%-18.38M | -8,984.84%-82.67M | -68.43%3.24M | -123.06%-679K | 143.69%10.76M | -127.63%-1.55M |
Operating gains losses | -52.38%10K | ---- | ---- | -69.24%406K | 233.33%20K | -98.25%21K | 71.56%187K | 2,866.67%178K | 22,100.00%1.32M | 102.31%6K |
Depreciation and amortization | -11.69%7.24M | -7.59%7.4M | -2.25%7.85M | -9.38%32.41M | -8.26%8.18M | -6.42%8.2M | -12.13%8.01M | -10.60%8.03M | 14.16%35.77M | -2.01%8.91M |
Deferred tax | -113.13%-3.66M | 664.95%4.3M | 87.21%-202K | 2,821.92%24.09M | -230.92%-2.79M | 2,729.50%27.9M | -43.80%562K | -7,995.00%-1.58M | 58.76%-885K | -204.69%-844K |
Other non cash items | -101.78%-966K | -8.05%-644K | 31.60%-461K | 1,637.73%52.25M | 86.18%-698K | 4,522.51%54.22M | -122.07%-596K | -478.65%-674K | 7.61%-3.4M | -44.85%-5.05M |
Change In working capital | 115.85%7.46M | 70.03%-5.65M | 106.79%562K | -163.27%-27.36M | 11.73%-3.69M | -23.17%3.46M | -240.18%-18.85M | -60.03%-8.28M | -398.42%-10.39M | -145.13%-4.18M |
-Change in receivables | ---- | ---- | ---- | -402.69%-8.44M | ---- | ---- | ---- | ---- | -16.22%2.79M | ---- |
-Change in other current assets | ---- | ---- | ---- | 25.14%6.46M | ---- | ---- | ---- | ---- | 347.03%5.16M | ---- |
-Change in other current liabilities | ---- | ---- | ---- | -15.49%-20.25M | ---- | ---- | ---- | ---- | -247.56%-17.53M | ---- |
-Change in other working capital | ---- | ---- | ---- | -531.49%-5.13M | ---- | ---- | ---- | ---- | 91.56%-813K | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 1.25%17.6M | 2,032.48%15.89M | 206.17%9.38M | -60.27%28.26M | -11.45%8.64M | -22.63%17.38M | -103.67%-822K | -81.43%3.06M | 67.62%71.14M | -62.18%9.76M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 12.19%-1.03M | -50.77%-1.66M | -87.79%-2.43M | 50.93%-5.64M | -26.79%-2.07M | 68.48%-1.17M | 54.44%-1.1M | 65.24%-1.29M | 94.10%-11.5M | 33.29%-1.64M |
Net PPE purchase and sale | 7.55%-1.31M | -40.91%-1.89M | -75.89%-2.62M | 35.37%-6.42M | -9.49%-2.17M | 21.48%-1.42M | 44.57%-1.34M | 60.01%-1.49M | 34.83%-9.93M | 37.48%-1.98M |
Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
Net other investing changes | 14.69%281K | -4.60%228K | -3.08%189K | 149.49%776K | -72.05%97K | --245K | --239K | --195K | -591.54%-1.57M | --347K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 12.19%-1.03M | -50.77%-1.66M | -87.79%-2.43M | 50.93%-5.64M | -26.79%-2.07M | 68.48%-1.17M | 54.44%-1.1M | 65.24%-1.29M | 94.10%-11.5M | 33.29%-1.64M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 86.70%-1.22M | 87.62%-1.03M | 72.53%-4.35M | 54.29%-35.82M | 87.72%-2.43M | 57.62%-9.19M | 59.96%-8.35M | 1.36%-15.85M | -141.38%-78.36M | -101.74%-19.75M |
Net issuance payments of debt | 0.00%-1.15M | 0.00%-1.15M | 0.00%-1.15M | 0.00%-4.6M | 0.00%-1.15M | 0.00%-1.15M | 0.00%-1.15M | 0.00%-1.15M | -101.99%-4.6M | 0.00%-1.15M |
Net common stock issuance | --0 | --0 | --0 | 90.01%-3.41M | --0 | --0 | --0 | -159.36%-3.41M | ---34.1M | ---10.31M |
Cash dividends paid | 99.91%-4K | 99.95%-2K | 87.87%-585K | 25.48%-13.55M | 98.55%-61K | -1.79%-4.5M | 5.78%-4.17M | 5.85%-4.82M | -1.98%-18.19M | 2.95%-4.22M |
Net other financing activities | 98.05%-69K | 103.90%118K | 59.52%-2.62M | 33.62%-14.26M | 70.20%-1.22M | 15.51%-3.55M | 35.87%-3.03M | 23.74%-6.47M | 11.53%-21.48M | 5.08%-4.08M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 86.70%-1.22M | 87.62%-1.03M | 72.53%-4.35M | 54.29%-35.82M | 87.72%-2.43M | 57.62%-9.19M | 59.96%-8.35M | 1.36%-15.85M | -141.38%-78.36M | -101.74%-19.75M |
Net cash flow | ||||||||||
Beginning cash position | 22.93%140.67M | 2.70%127.44M | -8.95%125.76M | -12.80%138.13M | -19.08%120.81M | -25.60%114.44M | -20.14%124.08M | -12.80%138.13M | 30.66%158.4M | 3.25%149.3M |
Current changes in cash | 118.73%15.35M | 228.36%13.19M | 118.45%2.6M | 29.51%-13.2M | 135.60%4.14M | 338.03%7.02M | -1,101.64%-10.27M | -328.06%-14.08M | -150.77%-18.72M | -185.78%-11.63M |
Effect of exchange rate changes | 155.63%356K | -92.03%50K | -2,820.59%-925K | 153.61%831K | 76.47%810K | 59.05%-640K | 187.08%627K | -87.59%34K | -616.67%-1.55M | 86.59%459K |
End cash Position | 29.44%156.38M | 22.93%140.67M | 2.70%127.44M | -8.95%125.76M | -8.95%125.76M | -19.08%120.81M | -25.60%114.44M | -20.14%124.08M | -12.80%138.13M | -12.80%138.13M |
Free cash flow | 2.04%16.29M | 746.67%13.99M | 329.33%6.76M | -64.31%21.85M | -16.79%6.47M | -22.73%15.97M | -110.82%-2.16M | -87.68%1.58M | 125.01%61.21M | -65.64%7.77M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |